C. Neil Lyons
Directeur/Bestuurslid bij Panacela Labs, Inc.
Profiel
C.
Neil Lyons is currently the Director at Panacela Labs, Inc. He previously worked as the CFO, Treasurer, CAO & Head-Investor Relations at RegeneRx Biopharmaceuticals, Inc. from 2005 to 2011.
He also worked as the Chief Financial Officer at HFS, Inc. and Vice President-Finance at SkyBridge LP.
From 1996 to 1998, he was a Senior Financial Executive at Bell Atlantic Corp.
He received his undergraduate degree from Florida Southern College.
Actieve functies van C. Neil Lyons
| Bedrijven | Functie | Begin |
|---|---|---|
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Directeur/Bestuurslid | 01-04-2014 |
Eerdere bekende functies van C. Neil Lyons
| Bedrijven | Functie | Einde |
|---|---|---|
| STATERA BIOPHARMA, INC. | Financieel Directeur/CFO | 06-05-2016 |
| REGENERX BIOPHARMACEUTICALS, INC. | Financieel Directeur/CFO | 31-08-2011 |
| HFS, Inc. | Financieel Directeur/CFO | 20-04-2005 |
| SkyBridge LP | Financieel Directeur/CFO | 01-01-2003 |
| Bell Atlantic Corp. | Corporate Officer/Principal | 01-01-1998 |
Opleiding van C. Neil Lyons
| Florida Southern College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| HFS, Inc. | Commercial Services |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
| Bell Atlantic Corp. | Communications |
| SkyBridge LP |